loader image
Monday, December 1, 2025
55.1 F
McAllen
- Advertisement -

Encouraging Cancer Screenings During Cervical Health Awareness Month 

Translate to Spanish or other 102 languages!

 As part of National Cervical Health Awareness Month this January, the Texas Health and Human Services Commission is encouraging women to get screened for cervical cancer. Image for illustration purposes
 As part of National Cervical Health Awareness Month this January, the Texas Health and Human Services Commission is encouraging women to get screened for cervical cancer. Image for illustration purposes
- Advertisement -

AUSTIN, Texas – As part of National Cervical Health Awareness Month this January, the Texas Health and Human Services Commission is encouraging women to get screened for cervical cancer.

“Routine cervical cancer screening is the most effective way to detect cervical cancer early,” said Faith Sandberg-Rodriguez, associate commissioner of Family Clinical Services at HHSC. “However, many potentially eligible Texas women may not know about services in their area or experience other barriers to accessing care. HHSC helps low-income women access timely cervical cancer screening and diagnostic services.”

Cervical cancer is the third-leading cancer diagnosis for women ages 20-39 and fifth-leading for women ages 40-49. According to the Texas Cancer Registry, an estimated 1,489 Texas women were diagnosed with cervical cancer. The Centers for Disease Control and Prevention (CDC) recommend cervical cancer screenings for women ages 21–65.

- Advertisement -

The HHSC Breast and Cervical Cancer Services (BCCS) program provides low-cost and free women’s health services for uninsured and underinsured Texas women who meet eligibility requirements. Services include cervical and breast cancer screenings, clinical breast examinations, mammograms and breast biopsies.

BCCS helps fund clinics across the state that provide these lifesaving screening and diagnostic services. In fiscal year 2022, BCCS served 30,422 women, including 5,717 women who received cervical cancer screenings.

The BCCS program is partly funded through the CDC. The National Breast and Cervical Cancer Early Detection Program awards funding to states for early detection of cervical and breast cancers. For fiscal year 2024, the federal program awarded BCCS more than $8.3 million. The Texas Legislature appropriated an additional $3.4 million in state funding.

To find BCCS providers or learn more about women’s health services, visit the Healthy Texas Women website or call 2-1-1. For more information on how breast and cervical cancer services are provided to Texas women, view “Breast and Cervical Cancer Services: 2023 Statewide Look.”

- Advertisement -

About National Cervical Health Awareness Month

National Cervical Health Awareness Month is observed in January in the U.S. Efforts throughout the month raise awareness about cervical cancer and provide education about prevention, screening and treatments. More information about cervical cancer is posted on the CDC website.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -
×